Walter Strapps of Idera to Speak at Nucleic Acid RD Meeting, June 19-20, 2014, San Diego, CA

San Diego, CA (PressExposure) April 01, 2014 -- Walter R. Strapps, Executive Director of RNA Therapeutics at Idera Pharmaceuticals, Inc., to give a presentation titled "Gene Silencing Oligos: The Next Generation in Gene Silencing" at the Inaugural Nucleic Acid Research and Development Conference, June 29 & 20, 2014 in San Diego, CA.

Dr. Strapps leads the RNA Discovery unit at Idera and is responsible for research and development of Idera's gene silencing oligo (GSO) platform. Dr. Strapps joined Idera in 2014. Prior to Idera, Dr. Strapps was Director, RNAi Therapeutics at Merck & Co., Inc. where he led siRNA lead identification and lead optimization efforts. Dr. Strapps holds a B.Sc. in Biology from McGill University and an M.A., M.Phil and Ph.D. in Genetics and Development from Columbia University.

Dr. Strapps talk will discuss:

- A unique oligonucleotide platform with two linked single strands
- Structure mitigates concerns and improves upon antisense
- Investigation into SAR provides opportunities for further optimization.

This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Nucleic Acid Field. A balance of both academic and industry experts will facilitate discussion on the following areas:

I. Nucleic Acid as a Drug Target I
II. Emerging Nucelic Acid Technologies
III. Aptamer Design and Application
IV. Nucleic Acid as a Drug Target II

This conference is also part of the 2014 Nucleic Acid Summit which consists of the following co-located conferences:

1. 4th Next-Generation Sequencing Conference
2. Non-Coding RNAs and RNAi Research & Therapeutics
3. Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data
4. Nucleic Acid Research & Discovery

For more information, please visit

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

GTC (Global Technology Community), LLC, is a privately held company founded in 2002.

About GTC

635 W. Foothill Blvd. Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 466-4433

Press Release Source:

Press Release Submitted On: April 01, 2014 at 10:52 pm
This article has been viewed 31020 time(s).